Biologix announced that it has received BRL 6 million in a round of funding led by new investor Kortex Ventures on May 7, 2024. The transaction included participation from new investors Fleury S.A., Laboratório Sabin de Análises Clínicas S.A., Bradesco Seguros S.A., Financial Investment Arm, and returning investor Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein.